Impact BioMedical Prices Initial Public Offering Of 1.5M Shares At $3.00 Per Share, Trading To Begin On NYSE American Under Symbol "IBO" On September 16, 2024
Portfolio Pulse from Benzinga Newsdesk
Impact BioMedical is set to launch its initial public offering (IPO) with 1.5 million shares priced at $3.00 each. The shares will begin trading on the NYSE American under the symbol 'IBO' on September 16, 2024.

September 16, 2024 | 2:26 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Impact BioMedical is launching its IPO with 1.5 million shares priced at $3.00 each, set to trade on NYSE American under 'IBO' on September 16, 2024.
The announcement of an IPO typically generates investor interest and can lead to an increase in stock price upon initial trading. The pricing at $3.00 per share and the listing on NYSE American are key details that will attract potential investors.
CONFIDENCE 95
IMPORTANCE 90
RELEVANCE 100